Authors
Martin, Stephen ACelli, Bartolome R.
DiFranza, Joseph R.
Krinzman, Stephen J.
Clarke, Jennifer G.
Beam, Herbert
Howard, Sandra
Foster, Melissa
Goldberg, Robert J.
UMass Chan Affiliations
Department of Medicine, Division of Pulmonary and Critical Care MedicineDepartment of Family Medicine and Community Health
Meyers Primary Care Institute
Department of Quantitative Health Sciences
Document Type
Journal ArticlePublication Date
2012-10-15Keywords
TobaccoSmoking
Smoking Cessation
Tobacco Use Cessation
Prisoners
Lung Diseases
Asthma
Community Health and Preventive Medicine
Health Services Research
Public Health
Respiratory Tract Diseases
Metadata
Show full item recordAbstract
BACKGROUND: Tobacco smoking remains the leading cause of preventable death in America, claiming 450,000 lives annually. Chronic Obstructive Pulmonary Disease, caused by smoking in the vast majority of cases, became the third leading cause of death in the U.S. in 2008. The burden of asthma, often exacerbated by tobacco exposure, has widespread clinical and public health impact. Despite this considerable harm, we know relatively little about the natural history of lung disease and respiratory impairment in adults, especially after smoking cessation. METHODS/DESIGN: Our paper describes the design and rationale for using the 2004 Federal Bureau of Prisons tobacco ban to obtain insights into the natural history of respiratory diseases in adult men and women of different races/ethnicities who are imprisoned in federal medical facilities. We have developed a longitudinal study of new prison arrivals, with data to be collected from each participant over the course of several years, through the use of standardized questionnaires, medical chart reviews, lung function tests, six-minute walk tests, and stored serum for the analysis of present and future biomarkers. Our endpoints include illness exacerbations, medication and health services utilization, lung function, serum biomarkers, and participants' experience with their health and nicotine addiction. DISCUSSION: We believe the proposed longitudinal study will make a substantial contribution to the understanding and treatment of respiratory disease and tobacco addiction.Source
BMC Pulm Med. 2012 Oct 15;12:64. doi: 10.1186/1471-2466-12-64. Link to article on publisher's siteDOI
10.1186/1471-2466-12-64Permanent Link to this Item
http://hdl.handle.net/20.500.14038/39595PubMed ID
23067295Related Resources
Link to Article in PubMedRights
© 2012 Martin et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.ae974a485f413a2113503eed53cd6c53
10.1186/1471-2466-12-64